Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Namba N et al. – Allogeneic peripheral blood stem cell (PBSC) transplantation is widely performed as a curative therapy for hematopoietic malignancies. Donors for PBSC harvest (PBSCH) are usually healthy subjects and undergo granulocyte–colony–stimulating factor treatment and apheresis procedures. The statistical model developed to predict the number of apheresis procedures for PBSCH may be useful for planning PBSCH in clinical practice.

Related Articles

Retrospective Analysis of Long-term Lipid Apheresis at a Single Center
Therapeutic Apheresis and Dialysis, 11/05/09    Relevance Score: 88%

Moderate and severe adverse events associated with apheresis donations: incidences and risk factors
Transfusion, 10/26/09    Relevance Score: 88%

Detection of bacterial contamination of apheresis platelets in a Chinese Blood Center
Transfusion Medicine, 11/09/09    Relevance Score: 82%

Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform
Transfusion, 10/09/09    Relevance Score: 80%

Leukocyte apheresis in the management of ulcerative colitis
Saudi Journal of Gastroenterology, 10/05/09    Relevance Score: 80%

Today in Hematology/Oncology...keeping you current

Effects of biological drug adalimumab on tumour necrosis factor-alpha-converting enzyme activation
Immunology & Cell Biology, 12/08/09

The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/07/09

Small-for-size liver graft injury--impact on tumor behavior
Transplantation Reviews, 12/07/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address